Alembic Pharmaceuticals consolidated net profit rises 11.46% in the March 2021 quarter

Sales rise 6.10% to Rs 1280.39 crore

Net profit of Alembic Pharmaceuticals rose 11.46% to Rs 250.70 crore in the quarter ended March 2021 as against Rs 224.93 crore during the previous quarter ended March 2020. Sales rose 6.10% to Rs 1280.39 crore in the quarter ended March 2021 as against Rs 1206.83 crore during the previous quarter ended March 2020.

For the full year,net profit rose 42.14% to Rs 1178.11 crore in the year ended March 2021 as against Rs 828.82 crore during the previous year ended March 2020. Sales rose 17.10% to Rs 5393.13 crore in the year ended March 2021 as against Rs 4605.75 crore during the previous year ended March 2020.

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales1280.391206.83 6 5393.134605.75 17 OPM %26.6927.14 -28.8826.55 - PBDT343.08320.66 7 1551.551200.79 29 PBT291.86276.52 6 1368.081043.47 31 NP250.70224.93 11 1178.11828.82 42

Powered by Capital Market - Live News